Invited Commentary: The Causal Association Between Obesity and Stillbirth-Strengths and Limitations of the Consecutive-Pregnancies Approach.

birth outcomes causal inference generalizability obesity pregnancy stillbirth

Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 07 2019
Historique:
received: 29 01 2019
revised: 16 02 2019
accepted: 18 02 2019
pubmed: 22 5 2019
medline: 19 3 2020
entrez: 22 5 2019
Statut: ppublish

Résumé

There has been a resurgence in analyses of consecutive pregnancies (or similarly, sibling designs) in perinatal and pediatric epidemiology. These approaches have attractive qualities for estimating associations with complex multifactorial exposures like obesity. In an article appearing in this issue of the Journal, Yu et al. (Am J Epidemiol. 2019;188(7):1328-1336) apply a consecutive-pregnancies approach to characterize the risk of stillbirth among women who develop obesity between pregnancies ("incident obesity"). Working within a causal framework and using parametric and nonparametric estimation techniques, the authors find an increase in stillbirth risk associated with incident obesity. Risk differences varied between 0.4 per 1,000 births (95% confidence interval (CI): 0.1, 0.7) and 6.9 per 1,000 births (95% CI: 3.7, 10.0), and risk ratios ranged from 1.12 (95% CI: 1.02, 1.23) to 2.99 (95% CI: 2.19, 4.08). The strengths of this approach include starting from a clearly defined causal estimand and exploring the sensitivity of parameter estimates to model selection. In this commentary, we put these findings in the broader context of research on obesity and birth outcomes and highlight concerns regarding the generalizability of results derived from within-family designs. We conclude that while causal inference is an important goal, in some instances focusing on formulation of a causal question drives results away from broad applicability.

Identifiants

pubmed: 31111943
pii: 5421027
doi: 10.1093/aje/kwz079
pmc: PMC6601522
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

1337-1342

Subventions

Organisme : NICHD NIH HHS
ID : F32 HD091945
Pays : United States
Organisme : NICHD NIH HHS
ID : R00 HD079658
Pays : United States

Commentaires et corrections

Type : CommentOn
Type : CommentIn

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Epidemiology. 2004 Jan;15(1):79-85
pubmed: 14712150
Lancet. 2006 Sep 30;368(9542):1164-70
pubmed: 17011943
Am J Clin Nutr. 2010 May;91(5):1499S-1505S
pubmed: 20335542
Int J Epidemiol. 2011 Apr;40(2):345-9
pubmed: 21450688
Lancet. 2011 Apr 16;377(9774):1331-40
pubmed: 21496916
Diabetes Care. 2011 Sep;34(9):1986-91
pubmed: 21775760
Gynecol Obstet Invest. 2011;72(3):192-5
pubmed: 21849757
JAMA. 2011 Dec 14;306(22):2459-68
pubmed: 22166605
Prev Med. 2013 Jun;56(6):372-8
pubmed: 23454595
Int J Epidemiol. 2014 Feb;43(1):83-90
pubmed: 24058000
Am J Obstet Gynecol. 2014 May;210(5):457.e1-9
pubmed: 24674712
BMJ. 2014 Jul 23;349:g4333
pubmed: 25056260
Epidemiology. 2014 Sep;25(5):729-37
pubmed: 25061922
Pediatrics. 2014 Sep;134(3):e806-13
pubmed: 25092933
BMJ. 2015 Jun 24;350:h3080
pubmed: 26109551
Lancet. 2016 Feb 13;387(10019):691-702
pubmed: 26794070
J Clin Endocrinol Metab. 2016 Aug;101(8):3088-95
pubmed: 27218274
Am J Epidemiol. 2016 Jul 15;184(2):98-105
pubmed: 27358265
PLoS Med. 2016 Aug 16;13(8):e1002081
pubmed: 27529652
J Clin Endocrinol Metab. 2016 Nov;101(11):4117-4124
pubmed: 27552544
Obstet Gynecol. 2017 Mar;129(3):408-415
pubmed: 28178044
Obstet Gynecol. 2017 Mar;129(3):405-407
pubmed: 28178065
Am J Epidemiol. 2019 Jul 1;188(7):1328-1336
pubmed: 31111944
Ann Hum Genet. 1969 Jul;33(1):71-9
pubmed: 5387613
Annu Rev Public Health. 1998;19:17-34
pubmed: 9611610

Auteurs

Jonathan M Snowden (JM)

School of Public Health, Oregon Health & Science University and Portland State University, Portland, Oregon.
Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon.

Stephanie A Leonard (SA)

Division of Neonatal and Developmental Medicine, Department of Pediatrics, School of Medicine, Stanford University, Stanford, California.
Center for Population Health Sciences, School of Medicine, Stanford University, Stanford, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH